144 related articles for article (PubMed ID: 7921203)
1. Aldosterone response to adrenocorticotrophin and furosemide in primary aldosteronism after prolonged spironolactone treatment.
Yagi A; Ichikawa S; Sakamaki T; Ono Z; Sato K; Nakamura T; Sakamoto H; Murata K
Eur J Endocrinol; 1994 Sep; 131(3):215-20. PubMed ID: 7921203
[TBL] [Abstract][Full Text] [Related]
2. Primary aldosteronism: effects of inhibition of ACTH and potassium administration on plasma aldosterone concentration.
Ganguly A; Luetscher JA; Weinberger MH
Clin Exp Hypertens A; 1982; 4(9-10):1695-714. PubMed ID: 6291813
[TBL] [Abstract][Full Text] [Related]
3. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
4. Control of plasma aldosterone in a patient with Conn's syndrome before and during spironolactone medication.
Vetter H; Vetter W
Klin Wochenschr; 1975 Apr; 53(8):391-3. PubMed ID: 211313
[TBL] [Abstract][Full Text] [Related]
5. An unexpected rise in plasma aldosterone to furosemide-upright test in primary aldosteronism due to aldosterone producing adenoma.
Shigemasa C; Kouchi T; Yoshida A; Mashiba H
J Med; 1991; 22(3):187-93. PubMed ID: 1663149
[TBL] [Abstract][Full Text] [Related]
6. [Plasma aldosterone levels in primary aldosteronism. 1. Renin-angiotensin system and aldosterone].
Fukuchi S; Takenouchi T; Nakajima K
Nihon Naibunpi Gakkai Zasshi; 1973 May; 49(5):781-7. PubMed ID: 4353260
[No Abstract] [Full Text] [Related]
7. Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism.
Mizuno K; Yamazaki M; Ikeda K; Yaginuma K; Hashimoto S; Fukuchi S
Jpn Heart J; 1983 Nov; 24(6):917-24. PubMed ID: 6323781
[TBL] [Abstract][Full Text] [Related]
8. Dissociation of plasma atrial natriuretic peptide responses to upright posture and furosemide administration in patients with normal-, low renin essential hypertension and primary aldosteronism.
Sergev O; Rácz K; Varga I; Kiss R; Fütö L; Gutkowska J; Gláz E
Clin Exp Hypertens A; 1991; 13(3):409-23. PubMed ID: 1832596
[TBL] [Abstract][Full Text] [Related]
9. [Effect of furosemide and ACTH on plasma renin, aldosterone and cortisol levels in normal man].
Cénac A; London A; Ménard J; Corvol P
Ann Endocrinol (Paris); 1975; 36(3):153-62. PubMed ID: 172005
[TBL] [Abstract][Full Text] [Related]
10. A simplified screening test for differentiating primary aldosteronism from essential hypertension with low plasma renin activity.
Honda M; Izumi Y; Tsuchiya M; Ueda Y; Watanabe H; Inoue T; Shiratsuchi T; Hatano M
Jpn Circ J; 1980 Sep; 44(9):719-25. PubMed ID: 6997525
[TBL] [Abstract][Full Text] [Related]
11. Activation of aldosterone secretion in primary aldosteronism.
Spark RF; Dale SL; Kahn PC; Melby JC
J Clin Invest; 1969 Jan; 48(1):96-104. PubMed ID: 4303791
[TBL] [Abstract][Full Text] [Related]
12. In vitro responses of aldosterone-producing adenomas to angiotensin II and ACTH after treatment with spironolactone before adrenalectomy.
Wisgerhof M
J Lab Clin Med; 1984 Aug; 104(2):160-5. PubMed ID: 6086794
[TBL] [Abstract][Full Text] [Related]
13. Studies of impaired aldosterone response to spironolactone-induced renin and potassium elevations in adenomatous but not hyperplastic primary aldosteronism.
Kater CE; Biglieri EG; Schambelan M; Arteaga E
Hypertension; 1983; 5(6 Pt 3):V115-21. PubMed ID: 6360878
[TBL] [Abstract][Full Text] [Related]
14. [Various aspects of the regulation of aldosterone secretion].
Jungmann E; Ackerman A; Panijel-Rath C; Schöffling K
Med Klin Prax; 1982 Apr; 77(8):58-63. PubMed ID: 6281634
[TBL] [Abstract][Full Text] [Related]
15. Time-related changes in plasma adrenal steroids during treatment with spironolactone in primary aldosteronism.
Sakamoto H; Ichikawa S; Sakamaki T; Nakamura T; Ono Z; Takayama Y; Murata K
Am J Hypertens; 1990 Jul; 3(7):533-7. PubMed ID: 2194510
[TBL] [Abstract][Full Text] [Related]
16. [Plasma-aldosterone and renin activity in Bartter's syndrome (author's transl)].
Rössler R
Dtsch Med Wochenschr; 1975 Nov; 100(47):2443-8. PubMed ID: 171132
[TBL] [Abstract][Full Text] [Related]
17. Plasma renin activity and urinary aldosterone in Cushing's syndrome.
Mantero F; Armanini D; Boscaro M
Horm Metab Res; 1978 Jan; 10(1):65-71. PubMed ID: 204567
[TBL] [Abstract][Full Text] [Related]
18. Reduced aldosterone secretion during spironolactone treatment in primary aldosteronism: report of a case.
Sundsfjord JA; Marton P; Jorgensen H; Aakvaag A
J Clin Endocrinol Metab; 1974 Oct; 39(4):734-9. PubMed ID: 4370321
[No Abstract] [Full Text] [Related]
19. [Plasma aldosterone levels in primary aldosteronism. II. Aldosterone and ACTH].
Fukuchi S; Takenouchi T; Nakajima K; Sasaki C
Nihon Naibunpi Gakkai Zasshi; 1973 Jul; 49(7):981-7. PubMed ID: 4353327
[No Abstract] [Full Text] [Related]
20. Simplified screening procedures for primary aldosteronism. Studies on the mechanism of the hyper-responsiveness to furosemide and standing.
Streeten DH; Anderson GH
Clin Exp Hypertens A; 1982; 4(9-10):1663-76. PubMed ID: 6754148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
